Search for persons
X
?
1
Baseline factors associated with early improvement of neuro..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.s006. , 2023
doi:10.1371/journal.pntd.0011707.s006. , 2023
?
2
Baseline factors associated with early improvement of coagu..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.t006. , 2023
doi:10.1371/journal.pntd.0011707.t006. , 2023
?
3
Factors associated with improvement of neurotoxic signs (AF..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.s007. , 2023
doi:10.1371/journal.pntd.0011707.s007. , 2023
?
4
Baseline factors associated with early improvement of coagu..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.s004. , 2023
doi:10.1371/journal.pntd.0011707.s004. , 2023
?
5
Time to stop of neurotoxic signs (N = 23) in patients recei..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.g006. , 2023
doi:10.1371/journal.pntd.0011707.g006. , 2023
?
6
Patient's clinical presentation at the time of admission:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.g002. , 2023
doi:10.1371/journal.pntd.0011707.g002. , 2023
?
7
Time to improvement of edema (N = 335) in patients receivin..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.g004. , 2023
doi:10.1371/journal.pntd.0011707.g004. , 2023
?
8
Location of centers participating in the ESAA study [The ma..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.g001. , 2023
doi:10.1371/journal.pntd.0011707.g001. , 2023
?
9
Flowchart of antivenom administration in envenomed patient:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.g003. , 2023
doi:10.1371/journal.pntd.0011707.g003. , 2023
?
10
Sequalae observed in 9 patients during home visit:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.t007. , 2023
doi:10.1371/journal.pntd.0011707.t007. , 2023
?
11
Factors associated with disappearance of cytotoxicity signs..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.t005. , 2023
doi:10.1371/journal.pntd.0011707.t005. , 2023
?
12
Factors associated with complete stop bleeding (AFT model, ..:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.s005. , 2023
doi:10.1371/journal.pntd.0011707.s005. , 2023
?
13
Gradation of whole-blood clotting time on dry tube (WBCT):
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.s002. , 2023
doi:10.1371/journal.pntd.0011707.s002. , 2023
?
14
Time to stop bleeding (N = 117) in patients receiving IPA:
Jean-Philippe Chippaux ; Rodrigue Ntone ; David Benhammou...
doi:10.1371/journal.pntd.0011707.g005. , 2023
doi:10.1371/journal.pntd.0011707.g005. , 2023
?
15
Linear epitope mapping of the humoral response against SARS..:
Inès Vigan-Womas ; Jean-Louis Spadoni ; Thomas Poiret...
https://doi.org/10.1038/s41598-023-27810-1. , 2023
https://doi.org/10.1038/s41598-023-27810-1. , 2023